HDM Group chosen for pitch day of IBAN Association, USAID partner

HDM Group chosen for pitch day of IBAN Association, USAID partner

May 7, 2021 Press release 0

HDM Group is one of the 6 companies chosen among 60 to participate on May 14th in the IBAN Association Pitch Day related to the Invest.

This project was promoted by the United States Agency for International Development (USAID) through the INVEST initiative, to raise funds from private investors to provide financial support and assistance to selected Italian companies.

PEDAL Consulting along with three other companies has been chosen by the U.S. Embassy in Rome, to help companies involved in the fight against COVID-19.

Italy was one of the first countries affected by the pandemic and with the rapid spread of the virus around the world, the need for Italian companies to produce medical devices has increased more and more.

The goal of this initiative by the United States is a symbol of help to Italy to reduce the impact of the socio-economic consequences of the pandemic and give a contribution to companies engaged in research, development or production of therapies, vaccines or medical equipment. Ambassador Lewis M. Eisenberg said that the intent of this project is to celebrate the lasting partnership between our country and the United States, allowing different private sectors to integrate through their contribution to Italian, American and international companies.

INVEST ITALY is USAID’s way to mobilize private capital with a two-pronged approach. On the one side, using catalytic capital to get even more investment and on the other side providing technical assistance services to attract more investors.

Through this initiative, USAID will be able to support companies that demonstrate the greatest potential.

Considering the experience gained and the mission that led to the creation of the company, HDM Group has the ambitious goal of putting innovative technology at the service of people. To follow its purpose, HDM has submitted its application aiming to improve the quality of life of patients affected by Covid through the use of new technologies.